Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - LION bioscience AG (NasdaqNM:LEON)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs
Recent Events
Aug 30Price hit new 52-week low ($14.00)
Aug  8Earnings Announcement
Location
Im Neuenheimer Feld 515-517, D-69120
Heidelberg, Germany
Phone: (617) 245-5400
Fax: (617) 245-5401
Email: andrea.kreisselmeier@lionbioscience.com
Employees (last reported count): 441
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Computer Networks
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 40%
·Institutional: 1% (2% of float)
(24 institutions)
·Net Inst. Selling: 151.0K shares (+175.48%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
LION bioscience AG (LION) provides information and knowledge management solutions to significantly improve life science research and development (R&D) performance and productivity. These solutions integrate all R&D disciplines, spanning from genetics to early and late discovery through clinical trials. LION offers these solutions via two primary lines of business, i-biology and iD3. i-biology involves the installation and implementation of enterprise-wide horizontal information and knowledge management solutions as part of LION's Life Science Informatics (LSI) line of business. Integrated Drug Discovery and Diagnostics (iD3) involves the application of i-biology to LION's internal drug discovery program with the goal to out-license specific databases, polymorphism marker panels, and validated targets and leads.
More from Market Guide: Expanded Business Description

Financial Summary
LION bioscience AG is a developer of enterprise-wide R&D data analysis and information management systems and solutions for the life sciences and healthcare industry, enabling the use of IT for drug discovery. For the fiscal year ended 3/31/01, revenues totaled EUR23.3 million, up from EUR10.2 million. Net loss rose 90% to EUR23.9 million. Results reflect increased research and development fees from Bayer, offset by increased personnel and preferred conversion costs.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 8,900; after tax earnings were -13,100. (Preliminary; reported in thousands of Euro.)

More from Market Guide: Significant Developments

Officers

Position
Friedrich Von Bohlen, Ph.D.Chairman, CEO
Klaus SprockampCFO, Chief Operating Officer
Jan MousCSO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:LEONAs of 31-Aug-2001
Price and Volume
52-Week Low
on 30-Aug-2001
$14.00 
Recent Price$14.25 
52-Week High
on 6-Sep-2000
$108.375
Daily Volume (3-month avg)8,864 
Daily Volume (10-day avg)4,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change-84.4%
52-Week Change
relative to S&P500
-79.0%
Share-Related Items
Market Capitalization$267.2M
Shares Outstanding18.8M
Float11.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$11.74 
Earnings (ttm)-$1.06 
Earnings (mrq)-$0.55 
Sales (ttm)$1.40 
Cash (mrq*)$3.26 
Valuation Ratios
Price/Book (mrq*)1.21 
Price/EarningsN/A 
Price/Sales (ttm)10.19 
Income Statements
Sales (ttm)$26.3M
EBITDA (ttm*)-$22.6M
Income available to common (ttm)-$20.9M
Profitability
Profit Margin (ttm)-79.6%
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-11.71%
Return on Equity (ttm)-13.18%
Financial Strength
Current Ratio (mrq*)2.43 
Debt/Equity (mrq*)0.02 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short311.0K
Percent of Float2.8%
Shares Short
(Prior Month)
279.0K
Short Ratio51.83 
Daily Volume6,000 
ADR Information
Shares/ADR1
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001);   dollar amounts based on an exchange rate of 1.1 Euro/Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.